{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008152",
      "entity_text" : "metabolism",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q66K79",
      "entity_text" : "CPZ",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "CPZ induces a perturbation of oligodendrocyte metabolism characterized by a disease pathology resembling type III MS lesions, which are highly suggestive of a primary oligodendrocyte dystrophy rather than autoimmunity.",
  "reading_complete" : "2020-08-04T15:15:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:13:53Z",
  "trigger" : "induces",
  "evidence" : [ "CPZ induces a perturbation of oligodendrocyte metabolism" ],
  "pmc_id" : "4403969",
  "score" : 0
}